Harrison Gunn

ID: 1b83cf65-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Formycon and Lotus Expand Collaboration in Asia-Pacific Region to Pembrolizumab Biosimilar

Big Molecule Watch · February 19, 2026

FDA Approves BMS’s BREYANZI as First MZL CAR T Therapy

Big Molecule Watch · December 11, 2025

Hikma Launches Ustekinumab Biosimilar STARJEMZA

Big Molecule Watch · November 6, 2025

FDA Approves Seventh Denosumab Biosimilar: Richter and Hikma’s Enoby and Xtrenbo

Big Molecule Watch · October 2, 2025

FDA Approves Expanded Indication for Celltrion’s AVTOZMA for the Treatment of Cytokine Release Syndrome

Big Molecule Watch · August 28, 2025